Arcutis Biotherapeutics, Inc. (ARQT)
Develops topical creams treating psoriasis and eczema.
$28.42+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+98.9%
The outlook
Arcutis trades at $28.42 and sits firmly in the upper portion of its 52-week range, well above both its 50- and 200-day moving averages. Analysts are predominantly bullish with a "Strong Buy" consensus, and the average price target sits roughly 22% above the current price. The overall data picture leans decidedly constructive.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Price targetAvg target +22% vs current price
Analyst price target
~12-month · 8 analysts$34.63average target+21.8% vs now
Now $28.42
Low $33.00High $36.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.55B
52-wk high
$31.77
52-wk low
$13.70
50-day avg
$24.77
200-day avg
$25.16
Trailing P/E
—